Abstract
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are eruptive mucocutaneous blistering diseases that can yield severe scarring of the eyelids and ocular surface. This scarring frequently leads to significant consequences such as severe dry eye, photophobia, and decreased vision. The severe sequelae are difficult, if not impossible, to reverse and can lead to lifelong disability for the patients. When applied in the first week of the illness, amniotic membrane transplantation (AMT) has been shown to effectively and consistently prevent the more serious sequelae of SJS and TEN [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15]. The cases presented will explore various aspects of the ophthalmologic evaluation of acute SJS/TEN and decisions regarding the use of AMT in the acute phase of the disease, generally defined as the initial blistering portion of the disease that lasts anywhere from 2 to 4 weeks in most cases.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
John T, Foulks GN, John ME, et al. Amniotic membrane in the surgical management of acute toxic epidermal necrolysis. Ophthalmology. 2002;109:351–60.
Kobayashi A, Yoshita T, Sugiyama K, et al. Amniotic membrane transplantation in acute phase of toxic epidermal necrolysis with severe corneal involvement. Ophthalmology. 2006;113:126–32.
Muquit M, Ellingham R, Daniel C. Technique of amniotic membrane transplant dressing in the management of acute Stevens-Johnson syndrome. Br J Ophthalmol. 2007;91:1536.
Tandon A, Cackett P, Mulvihill A, et al. Amniotic membrane grafting for conjunctival and lid surface disease in the acute phase of toxic epidermal necrolysis. J AAPOS. 2007;11:612–3.
Gregory DG. The ophthalmologic management of acute Stevens-Johnson syndrome. Ocul Surf. 2008;2:87–93.
Shay E, Kheirkhah A, Liang L, et al. Amniotic membrane transplantation as a new therapy for the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis. Surv Ophthalmol. 2009;54:686–96.
Shammas MC, Lai EC, Sarkar JS, et al. Management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis utilizing amniotic membrane and topical corticosteroids. Am J Ophthalmol. 2010;149:203–13.
Gregory DG. Treatment of acute Stevens-Johnson syndrome and toxic epidermal necrolysis using amniotic membrane: a review of 10 consecutive cases. Ophthalmology. 2011;118:908–14.
Kolomeyer AM, Do BK, Tu Y, et al. Placement of ProKera in the management of ocular manifestations of acute Stevens-Johnson syndrome in an outpatient. Eye Contact Lens. 2012;0:1–5.
Hsu M, Jayaram A, Verner R, et al. Indications and outcomes of amniotic membrane transplantation in the management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study. Cornea. 2012;31:1394–402.
Hess TM, Chew HF. Successful treatment of acute ocular involvement in Stevens-Johnson syndrome with amniotic membrane transplantation: a case report. Can J Ophthalmol. 2012;47:e44–6.
Barua A, McKee HD, Barbara R, et al. Toxic epidermal necrolysis in a 15-month-old girl successfully treated with amniotic membrane transplantation. J AAPOS. 2012;16:478–80.
Tomlins PJ, Parulekar MV, Rauz S. “Triple-TEN” in the treatment of acute ocular complications from toxic epidermal necrolysis. Cornea. 2013;32:365–9.
Ciralsky JB, Sippel KC. Prompt versus delayed amniotic membrane application in a patient with acute Stevens-Johnson syndrome. Clin Ophthalmol. 2013;7:1031–4.
Sharma N, Thenarasun SA, Kaur M, et al. Adjuvant role of amniotic membrane transplantation in acute ocular Stevens-Johnson syndrome: a randomized control trial. Ophthalmology. 2016;123:484–91.
Lopez-Garcia JS, Jara LR, Garcia-Lozano CI, et al. Ocular features and histopathologic changes during follow-up of toxic epidermal necrolysis. Ophthalmology. 2011;118:265–71.
Gueudry J, Roujeau JC, Binaghi M, et al. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol. 2009;145:157–62.
Morales ME, Purdue GF, Verity SM, et al. Ophthalmic manifestations of Stevens-Johnson syndrome and toxic epidermolysis and relation to SCORTEN. Am J Ophthalmol. 2010;150:505–10.
Di Pascuale MA, Espana EM, Liu DT, et al. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome. Ophthalmology. 2005;112:904–12.
McGee T, Munster A. Toxic epidermal necrolysis; mortality rate reduced with early referral to a regional burn center. Plast Reconstr Surg. 1998;102:1018–22.
Araki Y, Sotozono C, Inatomi T, et al. Successful Treatment of Stevens-Johnson Syndrome with Steroid Pulse Therapy at Disease Onset. Am J Ophthalmol. 2009;147(6):1004–11.e1.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Ciralsky, J.B., Sippel, K.C., Gregory, D.G. (2018). Evaluation and Management of Acute Stevens-Johnson Syndrome. In: Djalilian, A. (eds) Ocular Surface Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-15823-5_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-15823-5_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15822-8
Online ISBN: 978-3-319-15823-5
eBook Packages: MedicineMedicine (R0)